Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $374,824.00 |
|---|---|
| Enterprise Value | $3.37 Million |
| Earnings per Share | $-0.03 |
| Beta | 0.98 |
| Outstanding Shares | 46,274,624 |
| P/E Ratio | -2.18 |
|---|---|
| PEG | 7.64 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.62 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -0.5 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the ...